AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,189 | -7.3% | 19,078 | 0.0% | 0.00% | – |
| Q2 2023 | $31,479 | -89.4% | 19,078 | -74.5% | 0.00% | – |
| Q2 2021 | $297,000 | -67.0% | 74,757 | -56.7% | 0.00% | – |
| Q1 2021 | $899,000 | -7.2% | 172,697 | -4.6% | 0.00% | – |
| Q4 2020 | $969,000 | +10.1% | 181,110 | 0.0% | 0.00% | – |
| Q3 2020 | $880,000 | +235.9% | 181,110 | +236.0% | 0.00% | – |
| Q2 2020 | $262,000 | +61.7% | 53,908 | +130.6% | 0.00% | – |
| Q1 2019 | $162,000 | – | 23,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |